Small Molecules in Oncology

Nonfiction, Health & Well Being, Medical, Specialties, Oncology
Cover of the book Small Molecules in Oncology by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319914428
Publisher: Springer International Publishing Publication: August 1, 2018
Imprint: Springer Language: English
Author:
ISBN: 9783319914428
Publisher: Springer International Publishing
Publication: August 1, 2018
Imprint: Springer
Language: English

This book, written by respected experts, discusses in detail the latest developments in targeted oncology therapy using small molecules. It covers a wide range of small molecules, including tyrosine kinase inhibitors, mTOR, MEK, PARP, and multikinase inhibitors, as well as cell cycle and NTRK interacting agents. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. This book is the third edition of Small Molecules in Oncology, but has now been divided into two volumes, with the other volume focusing specifically on small molecules in hematology. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book, written by respected experts, discusses in detail the latest developments in targeted oncology therapy using small molecules. It covers a wide range of small molecules, including tyrosine kinase inhibitors, mTOR, MEK, PARP, and multikinase inhibitors, as well as cell cycle and NTRK interacting agents. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. 

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. This book is the third edition of Small Molecules in Oncology, but has now been divided into two volumes, with the other volume focusing specifically on small molecules in hematology. 

More books from Springer International Publishing

Cover of the book Formal Aspects of Component Software by
Cover of the book Advances in Biomedical Informatics by
Cover of the book New Perspectives on the History of Political Economy by
Cover of the book Population Reconstruction by
Cover of the book Green, Pervasive, and Cloud Computing by
Cover of the book Geographies of Transport and Ageing by
Cover of the book Judges, Judging and Humour by
Cover of the book Human-Computer Interaction. Interaction in Context by
Cover of the book Writing Migration through the Body by
Cover of the book A History of Orthodox, Islamic, and Western Christian Political Values by
Cover of the book Personality in Nonhuman Animals by
Cover of the book Handbook of Social Movements Across Disciplines by
Cover of the book Teaching Gender and Sex in Contemporary America by
Cover of the book Extraction 2018 by
Cover of the book Genetic Technology and Food Safety by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy